Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology.
Veronica AgostinelliZelmira BallatoreGiulia RicciAlessandra LucarelliMichela BurattiniLorenzo MariottiClaudia CataniValentina TarantinoRossana BerardiPublished in: Exploration of targeted anti-tumor therapy (2023)
Among all modifiers, investigators would prefer to maintain the positive ones such as pragmatic and simplified trial designs and protocols, reducing in-person visits when not necessary and to minimizing sponsor and contract research organizations (CROs) visits.